High expression level of EDIL3 in HCC predicts poor prognosis of HCC patients

Table 1 Relation between epidermal growth factor-like repeats and discoidin I-like domains 3 expression in hepatocellular carcinoma and clinicopathological features of hepatocellular carcinoma patients

Clinicopathologic features (n)	Low EDIL3 (total score < 4) n = 52	High EDIL3 (total score ≥ 4) n = 49	P value
Age (yr)			0.889
< 60 (57)	29	28
≥ 60 (44)	23	21
Gender			0.648
Male (87)	44	43
Female (14)	8	6
Tumor size (cm)			0.491
< 5 (26)	16	10
5-10 (58)	28	30
> 10 (17)	8	9
Histological differentiation			0.379
Well (17)	9	8
Moderate (63)	35	28
Poor (21)	8	13
Liver cirrhosis			0.617
Yes (50)	27	23
No (51)	25	26
Metastasis			0.202
Yes (15)	10	5
No (86)	42	44
Recurrence			0.817
Yes (38)	19	19
No (63)	33	30
HBSAg status			0.527
Positive (90)	45	45
Negative (11)	7	4
Serum AFP			0.707
Positive (62)	31	31
Negative (39)	21	18

EDIL3: Epidermal growth factor-like repeats and discoidin I-like domains 3; HBSAg: Hepatitis B surface antigen; AFP: α-fetoprotein.